These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 32516133)
1. SPTBN1 suppresses the progression of epithelial ovarian cancer via SOCS3-mediated blockade of the JAK/STAT3 signaling pathway. Chen M; Zeng J; Chen S; Li J; Wu H; Dong X; Lei Y; Zhi X; Yao L Aging (Albany NY); 2020 Jun; 12(11):10896-10911. PubMed ID: 32516133 [TBL] [Abstract][Full Text] [Related]
2. MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3. Lin XM; Chen H; Zhan XL Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6906-6913. PubMed ID: 31486490 [TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3. Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582 [TBL] [Abstract][Full Text] [Related]
4. Piperlongumine inhibits the progression of osteosarcoma by downregulating the SOCS3/JAK2/STAT3 pathway via miR-30d-5p. Hu Y; Luo X; Zhou J; Chen S; Gong M; Deng Y; Zhang H Life Sci; 2021 Jul; 277():119501. PubMed ID: 33862108 [TBL] [Abstract][Full Text] [Related]
5. MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway. Li XD; Li XM; Gu JW; Sun XC Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5153-5159. PubMed ID: 29228427 [TBL] [Abstract][Full Text] [Related]
6. MiR-452-5p facilitates retinoblastoma cell growth and invasion via the SOCS3/JAK2/STAT3 pathway. Wu L; Huang G; Hong H; Xu X; Lu X; Li J J Biochem Mol Toxicol; 2023 Dec; 37(12):e23501. PubMed ID: 37632310 [TBL] [Abstract][Full Text] [Related]
7. MiR-340 affects gastric cancer cell proliferation, cycle, and apoptosis through regulating SOCS3/JAK-STAT signaling pathway. Xiao C; Hong H; Yu H; Yuan J; Guo C; Cao H; Li W Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):278-283. PubMed ID: 29658372 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib. Liu L; Zhang Z; Zhang G; Wang T; Ma Y; Guo W J Transl Med; 2020 Sep; 18(1):357. PubMed ID: 32951601 [TBL] [Abstract][Full Text] [Related]
9. Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer. Shang AQ; Wu J; Bi F; Zhang YJ; Xu LR; Li LL; Chen FF; Wang WW; Zhu JJ; Liu YY Cancer Biol Ther; 2017 May; 18(5):314-322. PubMed ID: 28448787 [TBL] [Abstract][Full Text] [Related]
10. Farnesoid X receptor activation induces antitumour activity in colorectal cancer by suppressing JAK2/STAT3 signalling via transactivation of SOCS3 gene. Li S; Xu Z; Guo J; Zheng J; Sun X; Yu J J Cell Mol Med; 2020 Dec; 24(24):14549-14560. PubMed ID: 33164339 [TBL] [Abstract][Full Text] [Related]
11. MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3. Liu HP; Zhang Y; Liu ZT; Qi H; Zheng XM; Qi LH; Wang JY Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9286-9294. PubMed ID: 31773696 [TBL] [Abstract][Full Text] [Related]
12. Glycochenodeoxycholate promotes the metastasis of gallbladder cancer cells by inducing epithelial to mesenchymal transition via activation of SOCS3/JAK2/STAT3 signaling pathway. Wang H; Zhan M; Liu Q; Wang J J Cell Physiol; 2020 Feb; 235(2):1615-1623. PubMed ID: 31347168 [TBL] [Abstract][Full Text] [Related]
13. SOCS3 overexpression enhances ADM resistance in bladder cancer T24 cells. Li MZ; Lai DH; Zhao HB; Chen Z; Huang QX; Situ J Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3005-3011. PubMed ID: 28742207 [TBL] [Abstract][Full Text] [Related]
14. Protective effects of SOCS3 overexpression in high glucose‑induced lung epithelial cell injury through the JAK2/STAT3 pathway. Duan WN; Xia ZY; Liu M; Sun Q; Lei SQ; Wu XJ; Meng QT; Leng Y Mol Med Rep; 2017 Sep; 16(3):2668-2674. PubMed ID: 28713982 [TBL] [Abstract][Full Text] [Related]
15. Mimetics of suppressor of cytokine signaling 3: Novel potential therapeutics in triple breast cancer. La Manna S; Lee E; Ouzounova M; Di Natale C; Novellino E; Merlino A; Korkaya H; Marasco D Int J Cancer; 2018 Nov; 143(9):2177-2186. PubMed ID: 29752723 [TBL] [Abstract][Full Text] [Related]
16. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer. Kim MS; Lee WS; Jeong J; Kim SJ; Jin W Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594 [TBL] [Abstract][Full Text] [Related]
17. OTX1 silencing suppresses ovarian cancer progression through inhibiting the JAK/STAT signaling. Zhang Q; Li X; Ren L; Gu X; Xiao N; Li N Tissue Cell; 2023 Jun; 82():102082. PubMed ID: 37027968 [TBL] [Abstract][Full Text] [Related]
18. MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma. Peng HY; Cheng YC; Hsu YM; Wu GH; Kuo CC; Liou JP; Chang JY; Jin SL; Shiah SG PLoS One; 2016; 11(7):e0158440. PubMed ID: 27367272 [TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of alpha6beta1 integrin. Colomiere M; Findlay J; Ackland L; Ahmed N Int J Biochem Cell Biol; 2009 May; 41(5):1034-45. PubMed ID: 18930836 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway. He T; Cui J; Wu Y; Sun X; Chen N Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]